Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanism of Action of TRAVATAN 0.004% in Glaucoma or Ocular Hypertension
NCT00061503Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Apr 2003
- Primary completion
- Mar 2004
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of travoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Apr 2003; status: completed.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00061503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00061503.